Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Sodium hydride | HCID 24758 | — |
| Reactant | 1H-imidazole-2-carbaldehyde | HCID 24955 | — |
| Reactant | Ammonium Chloride | HCID 25517 | — |
| Reactant | 1H-Imidazole-4-carbaldehyde | HCID 76428 | — |
| Reactant | Sodium ethoxide | HCID 2723922 | — |
| Reactant | 2-Chloromethyl 2-(trimethylsilyl)ethyl ether | HCID 2724271 | — |
| Reactant | HCID 57467870 | HCID 57467870 | — |
| Solvent | Ethanol | HCID 702 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 68484667 | HCID 68484667 | 45.4% |
Reaction Steps
1H-imidazole-4-carbaldehyde (1.05 g, 10.9 mmol) was added portion wise to a stirred suspension of NaH (0.437 g, 10.9 mmol) in 15 mL of DMF. After 1 hour a solution of SEM-Cl (1.93 mL, 10.9 mmol) in 3 mL of DMF was added dropwise over 10 minutes. The resulting solution was stirred for 3 hours at RT. The reaction mixture was partitioned between water and EtOAc. The organic layer was separated, dried over MgSO4 and evaporated to yellow oil. Purification was accomplished by silica gel column chromatography (40-100% EtOAc/hexanes) to afford the SEM protected imidazole carbaldehyde (1.8 g, 7.9 mmol) as a mixture of regioisomers. The mixture was dissolved in 5 mL of ethanol and azidoacetate (7.8 g, 15.1 mmol) was added. This solution was added to a solution of sodium ethoxide (8.91 mL, 23.86 mmol) at −20° C. After the addition was complete, the solution was stirred at −10° C. for 3 hours. The reaction mixture was poured into a saturated solution of ammonium chloride and extracted with ether 2×100 mL. The extracts were combined, dried over MgSO4, filtered and evaporated to an oil. Purification was accomplished by silica gel column chromatography (EtOAc/hexanes) to afford (1.111 g, 41% yield) of a yellow oil. The oil was dissolved in xylenes and heated to reflux for 3 hours. The solvent was evaporated under vacuum. Purification was accomplished by silica gel column chromatography (EtOAc/hexanes). The fractions collected contained multiple products and were combined. A second purification was accomplished by reverse-phase HPLC (water/acetonitrile with 0.1% TFA) to afford the title compound (0.088 g, 3%) as a solid. 1H NMR (400 MHz, CDCl3) δ ppm 10.80 (d, 1H), 8.77 (s, 1H), 6.97 (s, 1H), 5.71 (s, 2H), 4.38 (q, 2H), 3.41-3.84 (m, 2H), 1.39 (t, 3H), 0.83-1.11 (m, 2H), −0.03 (s, 9H).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08304419B2 |
|---|
| Source dataset | uspto-grants-2012_11 |
|---|
| ORD ID | ord-8a50a9ceb1af4f558f19ae4ce8d9b3c1 |
|---|
| Source note | uspto-grants-2012_11 |
|---|